Werner H, Kuchenbecker K, Hammann R
Immun Infekt. 1983 Jun;11(4):143-7.
The in vitro inhibitory activity of tinidazole, metronidazole, ornidazole, cefoxitin and moxalactam was determined against 150 isolates of clinically important anaerobes including Bacteroides fragilis, Bacteroides bivius and Clostridium perfringens by means of agar dilution tests. The members of 18 gramnegative and 14 grampositive species were inhibited by tinidazole at less than or equal to 0,01-8 micrograms/ml thus being without exception susceptible to the drug. A similar in vitro activity was recorded for metronidazole and ornidazole. Though cefoxitin and moxalactam generally had a good in vitro activity against most anaerobic species, single strains of Bacteroides thetaiotaomicron, B. distasonis, Clostridium difficile and Eubacterium rectale were resistant to these drugs. With regard to its in vitro activity, tinidazole seems to be a promising substance for the therapy of anaerobic infections.
采用琼脂稀释试验,测定了替硝唑、甲硝唑、奥硝唑、头孢西丁和莫拉酰胺对包括脆弱拟杆菌、二路拟杆菌和产气荚膜梭菌在内的150株临床重要厌氧菌的体外抑制活性。替硝唑对18种革兰氏阴性菌和14种革兰氏阳性菌的成员均有抑制作用,其抑菌浓度小于或等于0.01 - 8微克/毫升,因此无一例外对该药敏感。甲硝唑和奥硝唑也有类似的体外活性。虽然头孢西丁和莫拉酰胺通常对大多数厌氧菌种具有良好的体外活性,但个别泰奥塔姆拟杆菌、狄氏拟杆菌、艰难梭菌和直肠真杆菌菌株对这些药物耐药。就其体外活性而言,替硝唑似乎是治疗厌氧菌感染的一种有前景的药物。